Cosmetic Research Analysis
Q1 2026 cosmetic research coalesced around regenerative biomaterials, disease-responsive dermal delivery, and rigorous, mechanism-led clinical evidence. January seeded the quarter with cross-disciplinary signals linking environmental exposures to health (collagen–integrin signaling under nanoplastic stress) and with scalable platforms for human collagen and skin-retentive conjugates. February added practice-shaping trials (PLLA for temporal augmentation), a paradigm-shifting, time-resolved dosin